busulfan has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
Excerpt | Relevance | Reference |
---|---|---|
"Busulfan is a cytotoxic agent used in preconditioning for hematopoietic stem cell transplantation." | 1.46 | A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug Monitoring. ( Choi, JY; Chung, H; Hong, CR; Hong, KT; Kang, HJ; Lee, S; Park, KD; Shin, HY; Yu, KS, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, H | 1 |
Yu, KS | 1 |
Hong, KT | 1 |
Choi, JY | 1 |
Hong, CR | 1 |
Kang, HJ | 1 |
Park, KD | 1 |
Shin, HY | 1 |
Lee, S | 1 |
Cahu, X | 1 |
Labopin, M | 1 |
Giebel, S | 1 |
Aljurf, M | 1 |
Kyrcz-Krzemien, S | 1 |
Socié, G | 1 |
Eder, M | 1 |
Bonifazi, F | 1 |
Bunjes, D | 1 |
Vigouroux, S | 1 |
Michallet, M | 1 |
Stelljes, M | 1 |
Zuckerman, T | 1 |
Finke, J | 1 |
Passweg, J | 1 |
Yakoub-Agha, I | 1 |
Niederwieser, D | 1 |
Sucak, G | 1 |
Sengeløv, H | 1 |
Polge, E | 1 |
Nagler, A | 1 |
Esteve, J | 1 |
Mohty, M | 1 |
2 other studies available for busulfan and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug Monitoring.
Topics: Busulfan; Child, Preschool; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans | 2017 |
Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT.
Topics: Adult; Busulfan; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic S | 2016 |